Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

SOBP Inhibitors

Chemical inhibitors of SOBP can impede its function through various molecular interactions that affect the signaling pathways integral to SOBP's role in the cell. Staurosporine acts by inhibiting protein kinase C, which is upstream of SOBP; this interruption in signaling can diminish SOBP's participation in neuronal differentiation. Similarly, LY294002 targets PI3K, a kinase that can regulate the subcellular localization of SOBP, which is crucial for its transcriptional regulatory functions. The inhibition of PI3K by LY294002, therefore, can lead to a decrease in SOBP activity. U0126 targets MEK1/2, preventing the activation of ERK1/2 signaling, which is necessary for SOBP's involvement in neural development. SB203580 and SP600125 inhibit p38 MAP kinase and JNK, respectively; both kinases potentially phosphorylate SOBP, thereby influencing its activity in transcriptional regulation and DNA damage response. By impeding these kinases, SB203580 and SP600125 can reduce SOBP's functional engagement in these critical cellular processes.

Wortmannin, another PI3K inhibitor like LY294002, can disrupt signaling pathways that affect SOBP's gene regulation related to synaptic plasticity. Rapamycin acts on mTOR, a pathway component that impacts SOBP's role in neuronal differentiation and plasticity; inhibition by rapamycin can limit the protein's functional activity. PD98059, an MEK inhibitor, can decrease ERK pathway signaling, thereby reducing SOBP's influence on neuronal development. PP2 targets Src family kinases and can alter the signaling pathways that dictate SOBP's activity in neurodevelopment. Y-27632 inhibits ROCK, potentially affecting cytoskeletal dynamics with which SOBP is implicated, thus inhibiting its role in cell structure regulation. Finally, Gefitinib and Lapatinib, which target EGFR tyrosine kinase and HER2/EGFR, respectively, can disrupt downstream signaling pathways, which play a part in regulating SOBP's function in synaptic formation and plasticity. Through these diverse mechanisms, each chemical can contribute to the functional inhibition of SOBP by targeting specific signaling pathways and cellular processes.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine inhibits protein kinase C, a pathway component upstream of SOBP, leading to the inhibition of SOBP's role in neuronal differentiation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 inhibits PI3K, which is involved in the regulation of SOBP's subcellular localization, thus inhibiting SOBP's function in transcriptional regulation.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 inhibits MEK1/2, thus preventing the activation of ERK1/2 signaling that may be required for the proper function of SOBP in neural development.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 inhibits p38 MAP kinase, which may impact the phosphorylation state and activity of SOBP, inhibiting its role in transcriptional regulation.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 inhibits JNK, which could alter the phosphorylation state of SOBP, leading to inhibition of its function in DNA damage response.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin is a PI3K inhibitor that would inhibit the signaling pathways influencing SOBP's activity in the regulation of gene expression related to synaptic plasticity.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin inhibits mTOR, which is part of the signaling pathway that influences SOBP's function in neuronal differentiation and plasticity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059 selectively inhibits MEK, which would inhibit ERK pathway signaling, thereby inhibiting SOBP's function in neuronal development.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$92.00
$223.00
30
(1)

PP2 is an Src family kinase inhibitor, which could inhibit signaling pathways that regulate SOBP's activity in neurodevelopmental processes.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

Y-27632 inhibits ROCK, which could alter the cytoskeletal dynamics that SOBP is implicated in, thus inhibiting its role in cell structure regulation.